• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$29.53 -$0.11 (-0.37%)

REAL-TIME: Last trade at

Hill-Rom Holdings, Inc.

NYSE:HRC

Hill-Rom to Participate in the Goldman Sachs 33rd Annual Global Healthcare Conference

BofA/Merrill's medtech analyst research team holds a conference call

Hill-Rom Holdings' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)

Hill-Rom Appoints Alton Shader President of Hill-Rom North America

Hill-Rom Holdings Management Presents at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript)

Hill-Rom Holdings (HRC) Declares $0.125 Quarterly Dividend; 1.5% Yield

Hill-Rom to Participate in the Deutsche Bank Securities Health Care Conference

- Hill-Rom Holdings' CEO Discusses F2Q12 Results - Earnings Call Transcript

Hill-Rom sees adjusted FY12 EPS $2.45-$2.50, consensus $2.46

Hill-Rom reports Q2 EPS 59c , consensus 54c

Hill-Rom Reports Fiscal Second Quarter Results; Provides Third Quarter and Full Year Financial Outlook

FDA posts warning letter to Hill-Rom, disclosed by company on March 19

Piper Jaffray's medtech research team holds a conference call

Hill-Rom Holdings, Inc. Hosts Fiscal 2012 Second Quarter Earnings Webcast

Hill-Rom to incur pre-tax charge $14M-$17M in Q2

Hill-Rom says unit received FDA warning letter on March 6

Hill-Rom increases its quarterly dividend by 11%

Hill-Rom Holdings (HRC) Raises Quarterly Dividend 10.6% to $0.125; 1.5% Yield

Hill-Rom Increases Second Quarter 2012 Dividend

Hill-Rom Holdings Management Presents at Citi Global Health Care Conference (Transcript)

Goldman Sachs Raises Price Target On Hill-Rom Holdings (HRC)

Hill-Rom to Participate in the Citi 2012 Global Healthcare Conference

Afterburner, Inc. Engages with Hill-Rom Holdings, Inc. to Provide Week-Long Flawless Execution(SM) Leadership Development Program

Hill-Rom completes $85M purchase of Volker

Hill-Rom Completes Acquisition of Volker

Hill-Rom Holdings' CEO Discusses F1Q 2012 Results - Earnings Call Transcript

Hill-Rom (HRC) Reports In-Line Q1 EPS; Issues Light Q2 EPS Outlook, Guides FY12 EPS

Hill-Rom sees FY12 EPS $2.45-$2.50 vs. consensus $2.46

Hill-Rom Reports Fiscal First Quarter Results; Provides Second Quarter and Full Year Financial Outlook

Piper Jaffray's medtech research team holds a conference call

Hill-Rom Holdings Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)

24/7 Wall St. Closing Bell (ALU, WBMD, URBN, RL, AWK, LEN, SVU, SHIP, LEDS, SNX, JASO, YRCW, CROX, HL, HRC)

Hill-Rom falls 11.3%

Hill-Rom gaps below its 50-day MA, support is at $30.34, resistance at $31.43

BofA/Merrill Lynch Drops Hill-Rom Holdings (HRC) to Underperform

Hill-Rom Holdings (HRC) Warns Of Q2 Earnings To Fall On Uncertain Economy

Hill-Rom narrows FY12 Adjusted EPS to $2.45-$2.50 from $2.45-$2.55

Hill-Rom reports preliminary Q1 EPS 52c-53c vs. consensus 56c

Hill-Rom to Participate in the 30th Annual J.P. Morgan Healthcare Conference

Hill-Rom announces definitive agreement to acquire Volker

See More Articles...